Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$192.5 - $216.35 $12,512 - $14,062
65 Added 5.15%
1,328 $270,000
Q1 2024

May 14, 2024

BUY
$209.01 - $232.56 $5,016 - $5,581
24 Added 1.94%
1,263 $275,000
Q4 2023

Mar 26, 2024

SELL
$197.69 - $227.29 $331,328 - $380,938
-1,676 Reduced 57.5%
1,239 $281,000
Q2 2022

Aug 15, 2022

SELL
$213.86 - $277.87 $119,761 - $155,607
-560 Reduced 16.12%
2,915 $711,000
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $34,902 - $39,159
-127 Reduced 3.53%
3,475 $978,000
Q2 2021

Jul 29, 2021

BUY
$251.87 - $278.14 $94,451 - $104,302
375 Added 11.62%
3,602 $994,000
Q1 2021

Apr 12, 2021

BUY
$204.88 - $255.03 $38,517 - $47,945
188 Added 6.19%
3,227 $822,000
Q4 2020

Feb 10, 2021

BUY
$186.91 - $214.42 $25,045 - $28,732
134 Added 4.61%
3,039 $689,000
Q3 2020

Nov 06, 2020

BUY
$167.03 - $201.3 $87,189 - $105,078
522 Added 21.91%
2,905 $623,000
Q2 2020

Aug 13, 2020

BUY
$113.31 - $182.44 $76,937 - $123,876
679 Added 39.85%
2,383 $398,000
Q1 2020

May 01, 2020

BUY
$104.32 - $195.28 $148,760 - $278,469
1,426 Added 512.95%
1,704 $278,000
Q1 2020

Apr 27, 2020

BUY
$104.32 - $195.28 $29,000 - $54,287
278 New
278 $1.7 Million
Q4 2019

Feb 13, 2020

SELL
$163.48 - $173.61 $150,074 - $159,373
-918 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $958 - $1,068
6 Added 0.66%
918 $154,000
Q2 2019

Aug 15, 2019

SELL
$144.16 - $172.9 $53,050 - $63,627
-368 Reduced 28.75%
912 $157,000
Q1 2019

May 08, 2019

BUY
$123.7 - $156.3 $158,336 - $200,064
1,280 New
1,280 $207,000
Q4 2018

Feb 20, 2019

SELL
$120.82 - $174.09 $141,480 - $203,859
-1,171 Closed
0 $0
Q3 2018

Oct 24, 2018

BUY
$167.67 - $188.27 $196,341 - $220,464
1,171 New
1,171 $198,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.